A Bayesian approach to stochastic cost-effectiveness analysis.
about
The probability of cost-effectivenessOn the probability of cost-effectiveness using data from randomized clinical trialsCost-effectiveness of genotypic antiretroviral resistance testing in HIV-infected patients with treatment failureBayesian cost-effectiveness analysis from clinical trial data.A framework for cost-effectiveness analysis from clinical trial data.Using inverse-weighting in cost-effectiveness analysis with censored data.The STRIDE (Strategies to Increase confidence, InDependence and Energy) study: cognitive behavioural therapy-based intervention to reduce fear of falling in older fallers living in the community - study protocol for a randomised controlled trialStatistical methods for cost-effectiveness analyses that use data from cluster randomized trials: a systematic review and checklist for critical appraisal.Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio.A randomised trial of adaptive pacing therapy, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome (PACE): statistical analysis plan.Risk-benefit trade-offs in revascularisation choices.The adoption of cost-effectiveness acceptability curves in cost-utility analyses.Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies.Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section.Medicoeconomic index for photo-induced skin cancers.Seasonal influenza vaccination for children in Thailand: a cost-effectiveness analysisIs shared care with annual hospital review better value for money than predominantly hospital-based care in patients with established stable rheumatoid arthritis?A Bayesian network approach to the study of historical epidemiological databases: modelling meningitis outbreaks in the NigerResource consumption of a diffusion model for prevention programs: the PROSPER delivery systemCost-effectiveness of adherence therapy versus health education for people with schizophrenia: randomised controlled trial in four European countries.Cost-effectiveness of cemented versus cementless total hip arthroplasty. A Markov decision analysis based on implant cost.Cost-effectiveness of aliskiren in type 2 diabetes, hypertension, and albuminuria.Regression models for analyzing costs and their determinants in health care: an introductory review.Sample size determination for cost-effectiveness trials.Cost-effectiveness of linezolid in methicillin-resistant Staphylococcus aureus skin and skin structure infections.Bayesian Methods for Calibrating Health Policy Models: A Tutorial.Impact of small study bias on cost-effectiveness acceptability curves and value of information analyses.Cost-effectiveness analysis of extended adjuvant endocrine therapy in the treatment of post-menopausal women with hormone receptor positive breast cancer.Choice of statistical model for cost-effectiveness analysis and covariate adjustment: empirical application of prominent models and assessment of their results.A Bayesian cost-effectiveness analysis of a telemedicine-based strategy for the management of sleep apnoea: a multicentre randomised controlled trial.A cost-utility analysis of tension-free vaginal tape versus colposuspension for primary urodynamic stress incontinence.Bayesian cost-effectiveness analysis based on the persistence with antihypertensive treatment.Estimating survival gain for economic evaluations with survival time as principal endpoint: a cost-effectiveness analysis of adding early hormonal therapy to radiotherapy in patients with locally advanced prostate cancer.Cost-effectiveness acceptability curves revisited.Randomised controlled trial to improve health and reduce substance use in established psychosis (IMPaCT): cost-effectiveness of integrated psychosocial health promotion.Representing uncertainty: the role of cost-effectiveness acceptability curves.Motivational enhancement therapy with and without cognitive behaviour therapy for Type 1 diabetes: economic evaluation from a randomized controlled trial.Twice-weighted multiple interval estimation of a marginal structural model to analyze cost-effectiveness.Economic endpoints in clinical trials.Presenting evidence and summary measures to best inform societal decisions when comparing multiple strategies.
P2860
Q24805121-FF35288F-E2DC-458B-81B5-E3CBB258A907Q24806506-6CACDEED-1E51-4C36-8550-7E993F71FB79Q28469116-0F63DDF7-41C2-4985-AC40-5D62028B4D86Q30637667-D974E516-8521-459F-9ED8-BED610246F08Q30654009-C709C876-EB2A-41AD-90E7-7D5E1A23A05FQ30760278-09D0F45D-4905-49F9-B40E-8C2717F14FE3Q33164400-000379E6-3258-428B-9DEE-4DC1D7924AAEQ33910824-C22FF17E-FF55-425E-B31D-BFA08C6D15AEQ33914367-B43D1A59-2625-4FCF-AAB6-C683715D5658Q34480158-947C1DB2-42CD-418D-8960-05EB817B5D0DQ34700769-705A5AC0-C74E-4093-ADE6-E51E67DA29EDQ35004608-FC498235-0CE1-4F51-93E5-EDE9A9F20E5EQ35040675-9AA777D2-E212-408A-9C03-BE8FFF1D7121Q35040678-9F39E31B-3F38-45F7-8063-84C5F551B95CQ35505542-85F4B91B-0A82-4463-8920-9F709D45F6DEQ35642206-67E7CBA9-F17D-4A9F-85F7-29AB3EA5D598Q35953211-5E09F3D1-DD7E-4F7A-BB28-BD8795B5ED48Q36017426-946D154B-975E-4211-A330-8263CBBC0754Q36862920-D268C2E6-0283-4FCE-8C56-661D36E77236Q36888900-BADF6994-D066-4C6D-A19A-C234CBE569E2Q37131566-94161344-C0B0-4A6C-993D-807818905789Q37367740-C9CF5D1E-390F-42CA-9188-D14575509E1BQ37866920-FB75277A-4A6C-4A13-8A13-133E337B7538Q37944317-DB346C36-5029-4086-80D5-690853C7631FQ38068456-48BF05CD-9C4B-458A-AC42-02C7EAB6D76DQ38936428-6934B8B5-D5C0-402B-A559-35A15BE2385BQ39190019-6CE7121D-F00B-48B6-876C-498C628FCAF6Q39202749-0F38227E-A28E-4ED0-A4F8-6FDDAB022D1BQ40456452-F8AF8564-D2FD-4E2E-8499-15CDA1C1445EQ40604494-ACC17F93-8233-4483-917C-EDC3A5744874Q42594763-EB0D6D08-51C7-469D-8570-56795442988CQ43266414-92BFFA75-E37D-4033-8F55-E5862B93D246Q43938713-B30C16FB-95D1-4EFA-ADD4-9191B8BE6BEEQ45710710-A249DDF2-ADB6-41D4-A8F1-83BD409B3289Q47098175-C5C386C0-297C-4177-AA5B-BFECB831C55CQ47573256-43D5EFDD-69B1-4B38-A20B-F2660C55FB36Q48148953-4B6B857B-2997-4AF4-A7AC-3ADD54FE7553Q50143763-EE528D10-9C1D-4292-AFFA-E1BB3202BAEDQ50490202-61E3B2B5-223F-435F-8D5E-F7C1097D136EQ51558387-C83A66DB-A654-4E65-B1BC-E84E33AE66C3
P2860
A Bayesian approach to stochastic cost-effectiveness analysis.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
A Bayesian approach to stochastic cost-effectiveness analysis.
@en
A Bayesian approach to stochastic cost-effectiveness analysis.
@nl
type
label
A Bayesian approach to stochastic cost-effectiveness analysis.
@en
A Bayesian approach to stochastic cost-effectiveness analysis.
@nl
prefLabel
A Bayesian approach to stochastic cost-effectiveness analysis.
@en
A Bayesian approach to stochastic cost-effectiveness analysis.
@nl
P2860
P1433
P1476
A Bayesian approach to stochastic cost-effectiveness analysis.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1099-1050(199905)8:3<257::AID-HEC427>3.0.CO;2-E
P407
P577
1999-05-01T00:00:00Z